Back

Latest Forum Topics / Aoxin Q & M    Last:0.275    -0.01

Post Reply

<No Title> Post Reply Rate topic
piscesmonkey Supreme	13-May-2026 14:14        piscesmonkey About Contact  Quote this Post!
x 0   x 1  Alert Admin	QM buying again every buying sure go above 30cents soon piscesmonkey      ( Date: 13-May-2026 10:25) Posted: QM keep buying going take to private ah Joelton      ( Date: 13-May-2026 10:11) Posted: UOBKH sees 38.5% upside in Aoxin Q& M Dental on back of China dental consolidation push Tang Kai Jie of UOB Kay Hian has initiated coverage on Aoxin Q& M Dental with a " buy" call and a target price of 36 cents, implying an upside of 38.5% from its current share price of 26 cents. Tang&rsquo s target price is pegged to an FY2027 P/E of 52.5 times and 2.5 standard deviations (s.d.) above historical averages, based on parent company Q& M Dental Group' s P/E band. In its FY2025 ended Dec 31, 2025 results, Aoxin delivered a significant earnings turnaround, swinging from a net loss of RMB8 million ($1.5 million) in FY2024 to a net profit of RMB7 million, driven primarily by a sharp narrowing of losses from its associate Acumen Diagnostics. Core net profit also grew 11.6% y-o-y to RMB7 million despite a 3.6% decline in revenue to RMB171 million, supported by improved cost discipline. On the revenue front, weakness in the primary healthcare segment was partially offset by stronger dental equipment distribution sales to government hospitals and higher laboratory services revenue from Singapore. " Primary healthcare remains the core earnings driver, and recurring demand from preventive and restorative treatments underpins strong revenue visibility over time," says Tang. Aoxin' s management is pursuing an aggressive acquisition-led expansion strategy into Central and Southern China, with two non-binding MOUs (memoranda of understanding) announced in 2026. The Central China target operates 30 clinics with around 80 dentists, valued at RMB150 million, while the Southern China target operates 15 clinics with around 60 dentists, valued at RMB376 million with consideration split evenly between cash and shares. If completed, the deals would nearly triple Aoxin' s current network to 59 clinics and add around 140 dentists, with Tang forecasting the acquisitions could contribute RMB32 million in profit in FY2027, lifting net profit nearly six-fold from RMB7 million to RMB40 million. According to Tang, Aoxin' s balance sheet is well-positioned to fund this growth, with net cash doubling to RMB255 million following a proposed $20 million placement of 134 million shares, of which parent company Q& M Dental subscribed for 50 million shares. Tang notes that China' s dental market remains highly fragmented and is estimated at RMB160 billion &ndash RMB200 billion, growing at 15%&ndash 20% annually, with organised dental chains expanding even faster at a compound annual growth rate (CAGR) of around 18%. This fragmentation creates a compelling consolidation runway for Aoxin as a well-capitalised, institutionally-backed operator, says Tang. Tang flags that despite the strong share price performance (up over 660% in the past three months), the near-term earnings contribution from acquisitions will take time to flow through, limiting upside in FY2026 where net profit is forecast at only RMB7.6 million on a 214 times FY2026 P/E before the step-change in 2027. In spite of the remaining completion risk, Tang still views the company&rsquo s risk-reward profile as &ldquo favourable, with sustained earnings momentum likely to catalyse a valuation re-rating over the next 12 months.&rdquo As at 10.33am on May 12, Aoxin Q& M Dental shares are trading at 26 cents flat.
Useful To Me  Not Useful To Me
piscesmonkey Supreme	13-May-2026 10:25        piscesmonkey About Contact  Quote this Post!
x 0   x 0  Alert Admin	QM keep buying going take to private ah Joelton      ( Date: 13-May-2026 10:11) Posted: UOBKH sees 38.5% upside in Aoxin Q& M Dental on back of China dental consolidation push Tang Kai Jie of UOB Kay Hian has initiated coverage on Aoxin Q& M Dental with a " buy" call and a target price of 36 cents, implying an upside of 38.5% from its current share price of 26 cents. Tang&rsquo s target price is pegged to an FY2027 P/E of 52.5 times and 2.5 standard deviations (s.d.) above historical averages, based on parent company Q& M Dental Group' s P/E band. In its FY2025 ended Dec 31, 2025 results, Aoxin delivered a significant earnings turnaround, swinging from a net loss of RMB8 million ($1.5 million) in FY2024 to a net profit of RMB7 million, driven primarily by a sharp narrowing of losses from its associate Acumen Diagnostics. Core net profit also grew 11.6% y-o-y to RMB7 million despite a 3.6% decline in revenue to RMB171 million, supported by improved cost discipline. On the revenue front, weakness in the primary healthcare segment was partially offset by stronger dental equipment distribution sales to government hospitals and higher laboratory services revenue from Singapore. " Primary healthcare remains the core earnings driver, and recurring demand from preventive and restorative treatments underpins strong revenue visibility over time," says Tang. Aoxin' s management is pursuing an aggressive acquisition-led expansion strategy into Central and Southern China, with two non-binding MOUs (memoranda of understanding) announced in 2026. The Central China target operates 30 clinics with around 80 dentists, valued at RMB150 million, while the Southern China target operates 15 clinics with around 60 dentists, valued at RMB376 million with consideration split evenly between cash and shares. If completed, the deals would nearly triple Aoxin' s current network to 59 clinics and add around 140 dentists, with Tang forecasting the acquisitions could contribute RMB32 million in profit in FY2027, lifting net profit nearly six-fold from RMB7 million to RMB40 million. According to Tang, Aoxin' s balance sheet is well-positioned to fund this growth, with net cash doubling to RMB255 million following a proposed $20 million placement of 134 million shares, of which parent company Q& M Dental subscribed for 50 million shares. Tang notes that China' s dental market remains highly fragmented and is estimated at RMB160 billion &ndash RMB200 billion, growing at 15%&ndash 20% annually, with organised dental chains expanding even faster at a compound annual growth rate (CAGR) of around 18%. This fragmentation creates a compelling consolidation runway for Aoxin as a well-capitalised, institutionally-backed operator, says Tang. Tang flags that despite the strong share price performance (up over 660% in the past three months), the near-term earnings contribution from acquisitions will take time to flow through, limiting upside in FY2026 where net profit is forecast at only RMB7.6 million on a 214 times FY2026 P/E before the step-change in 2027. In spite of the remaining completion risk, Tang still views the company&rsquo s risk-reward profile as &ldquo favourable, with sustained earnings momentum likely to catalyse a valuation re-rating over the next 12 months.&rdquo As at 10.33am on May 12, Aoxin Q& M Dental shares are trading at 26 cents flat.
Useful To Me  Not Useful To Me
Joelton Supreme	13-May-2026 10:11        Joelton About Contact  Quote this Post!
x 0   x 0  Alert Admin	UOBKH sees 38.5% upside in Aoxin Q& M Dental on back of China dental consolidation push Tang Kai Jie of UOB Kay Hian has initiated coverage on Aoxin Q& M Dental with a " buy" call and a target price of 36 cents, implying an upside of 38.5% from its current share price of 26 cents. Tang&rsquo s target price is pegged to an FY2027 P/E of 52.5 times and 2.5 standard deviations (s.d.) above historical averages, based on parent company Q& M Dental Group' s P/E band. In its FY2025 ended Dec 31, 2025 results, Aoxin delivered a significant earnings turnaround, swinging from a net loss of RMB8 million ($1.5 million) in FY2024 to a net profit of RMB7 million, driven primarily by a sharp narrowing of losses from its associate Acumen Diagnostics. Core net profit also grew 11.6% y-o-y to RMB7 million despite a 3.6% decline in revenue to RMB171 million, supported by improved cost discipline. On the revenue front, weakness in the primary healthcare segment was partially offset by stronger dental equipment distribution sales to government hospitals and higher laboratory services revenue from Singapore. " Primary healthcare remains the core earnings driver, and recurring demand from preventive and restorative treatments underpins strong revenue visibility over time," says Tang. Aoxin' s management is pursuing an aggressive acquisition-led expansion strategy into Central and Southern China, with two non-binding MOUs (memoranda of understanding) announced in 2026. The Central China target operates 30 clinics with around 80 dentists, valued at RMB150 million, while the Southern China target operates 15 clinics with around 60 dentists, valued at RMB376 million with consideration split evenly between cash and shares. If completed, the deals would nearly triple Aoxin' s current network to 59 clinics and add around 140 dentists, with Tang forecasting the acquisitions could contribute RMB32 million in profit in FY2027, lifting net profit nearly six-fold from RMB7 million to RMB40 million. According to Tang, Aoxin' s balance sheet is well-positioned to fund this growth, with net cash doubling to RMB255 million following a proposed $20 million placement of 134 million shares, of which parent company Q& M Dental subscribed for 50 million shares. Tang notes that China' s dental market remains highly fragmented and is estimated at RMB160 billion &ndash RMB200 billion, growing at 15%&ndash 20% annually, with organised dental chains expanding even faster at a compound annual growth rate (CAGR) of around 18%. This fragmentation creates a compelling consolidation runway for Aoxin as a well-capitalised, institutionally-backed operator, says Tang. Tang flags that despite the strong share price performance (up over 660% in the past three months), the near-term earnings contribution from acquisitions will take time to flow through, limiting upside in FY2026 where net profit is forecast at only RMB7.6 million on a 214 times FY2026 P/E before the step-change in 2027. In spite of the remaining completion risk, Tang still views the company&rsquo s risk-reward profile as &ldquo favourable, with sustained earnings momentum likely to catalyse a valuation re-rating over the next 12 months.&rdquo As at 10.33am on May 12, Aoxin Q& M Dental shares are trading at 26 cents flat.
Useful To Me  Not Useful To Me
Barcalo Master	13-May-2026 06:38        Barcalo About Contact  Quote this Post!
x 1   x 1  Alert Admin	At what price? spursfan      ( Date: 12-May-2026 21:50) Posted: Q & M acquired 1,000,000 ordinary shares in the capital of Aoxin on 12 May 2026 for a total consideration of S$260,000 (excluding brokerage & stamp duties) https://links.sgx.com/1.0.0/corporate-announcements/7STJH9HAF7X3AYI4/888532__eFORM3V2-QM%20and%20QMH-12052026.pdf SmallSmall      ( Date: 12-May-2026 14:16) Posted: Buyer at $0.26 came in 1 mil
Useful To Me  Not Useful To Me
spursfan Supreme	12-May-2026 21:50        spursfan About Contact  Quote this Post!
x 0   x 0  Alert Admin	Q & M acquired 1,000,000 ordinary shares in the capital of Aoxin on 12 May 2026 for a total consideration of S$260,000 (excluding brokerage & stamp duties) https://links.sgx.com/1.0.0/corporate-announcements/7STJH9HAF7X3AYI4/888532__eFORM3V2-QM%20and%20QMH-12052026.pdf SmallSmall      ( Date: 12-May-2026 14:16) Posted: Buyer at $0.26 came in 1 mil
Useful To Me  Not Useful To Me
Barcalo Master	12-May-2026 17:37        Barcalo About Contact  Quote this Post!
x 0   x 0  Alert Admin	This block still cannot clear..... Jialat. Barcalo      ( Date: 12-May-2026 09:27) Posted: Past few days road block at 270 & 275 keep building up. Don't think so easy to clear..... 😞
Useful To Me  Not Useful To Me
SmallSmall Supreme	12-May-2026 14:16        SmallSmall About Contact  Quote this Post!
x 0   x 0  Alert Admin	Buyer at $0.26 came in 1 mil
Useful To Me  Not Useful To Me
Barcalo Master	12-May-2026 09:27        Barcalo About Contact  Quote this Post!
x 0   x 0  Alert Admin	Past few days road block at 270 & 275 keep building up. Don't think so easy to clear..... 😞
Useful To Me  Not Useful To Me
TraderBen Supreme	12-May-2026 09:13        TraderBen About Contact  Quote this Post!
x 0   x 0  Alert Admin	wah like that make anything below 25 cents a steal.. SmallSmall      ( Date: 11-May-2026 21:13) Posted: Make sense for Q& M to hold Aoxin' s price elevated in order to make its China acqusitions cheaper.   spursfan      ( Date: 11-May-2026 19:30) Posted: Q & M acquired 6,151,800 ordinary shares in the capital of Aoxin on 11 May 2026 for a total consideration of S$1,634,471.74 (excluding brokerage & stamp duties). https://links.sgx.com/1.0.0/corporate-announcements/53YN1UM3U09KJU5G/888325__eFORM3V2-QM%20and%20QMH-11052026.pdf
Useful To Me  Not Useful To Me
SmallSmall Supreme	11-May-2026 21:13        SmallSmall About Contact  Quote this Post!
x 0   x 0  Alert Admin	Make sense for Q& M to hold Aoxin' s price elevated in order to make its China acqusitions cheaper.   spursfan      ( Date: 11-May-2026 19:30) Posted: Q & M acquired 6,151,800 ordinary shares in the capital of Aoxin on 11 May 2026 for a total consideration of S$1,634,471.74 (excluding brokerage & stamp duties). https://links.sgx.com/1.0.0/corporate-announcements/53YN1UM3U09KJU5G/888325__eFORM3V2-QM%20and%20QMH-11052026.pdf
Useful To Me  Not Useful To Me
spursfan Supreme	11-May-2026 19:30        spursfan About Contact  Quote this Post!
x 0   x 0  Alert Admin	Q & M acquired 6,151,800 ordinary shares in the capital of Aoxin on 11 May 2026 for a total consideration of S$1,634,471.74 (excluding brokerage & stamp duties). https://links.sgx.com/1.0.0/corporate-announcements/53YN1UM3U09KJU5G/888325__eFORM3V2-QM%20and%20QMH-11052026.pdf
Useful To Me  Not Useful To Me
SmallSmall Supreme	11-May-2026 09:09        SmallSmall About Contact  Quote this Post!
x 0   x 0  Alert Admin	Initiate Coverage | Aoxin Q & M Dental (AOXIN SP/BUY/S$0.26/Target: S$0.36) Backed by Q & M Dental Group, Aoxin is pursuing acquisitions in China to accelerate growth. 2025&rsquo s earnings turnaround and strong net cash support recent 2026 deals, potentially lifting earnings from Rmb7m in 2025 to Rmb40m in 2027. We initiate coverage with BUY and a target price of S$0.36, with catalysts from EPS-accretive acquisitions and improved price discovery as earnings scale up
Useful To Me  Not Useful To Me
piscesmonkey Supreme	08-May-2026 19:23        piscesmonkey About Contact  Quote this Post!
x 0   x 0  Alert Admin	Not easy to go down. QM keep buying spursfan      ( Date: 08-May-2026 18:59) Posted: Q & M acquired 3,000,000 ordinary shares in the capital of Aoxin on 8 May 2026 for a total consideration of S$789,990 (excluding brokerage & stamp duties). https://links.sgx.com/1.0.0/corporate-announcements/FTBHCYOYPU2ZAGHQ/888141__eFORM3V2-QM%20and%20QMH-08052026.pdf
Useful To Me  Not Useful To Me
spursfan Supreme	08-May-2026 18:59        spursfan About Contact  Quote this Post!
x 0   x 0  Alert Admin	Q & M acquired 3,000,000 ordinary shares in the capital of Aoxin on 8 May 2026 for a total consideration of S$789,990 (excluding brokerage & stamp duties). https://links.sgx.com/1.0.0/corporate-announcements/FTBHCYOYPU2ZAGHQ/888141__eFORM3V2-QM%20and%20QMH-08052026.pdf
Useful To Me  Not Useful To Me
piscesmonkey Supreme	08-May-2026 09:51        piscesmonkey About Contact  Quote this Post!
x 0   x 0  Alert Admin	Going 190? Placement selling?
Useful To Me  Not Useful To Me
piscesmonkey Supreme	08-May-2026 09:49        piscesmonkey About Contact  Quote this Post!
x 0   x 0  Alert Admin	Once i mention i already gtm haha TraderBen      ( Date: 08-May-2026 09:09) Posted: u que since last night ah? piscesmonkey      ( Date: 08-May-2026 09:05) Posted: Sold off 100lots at 26
Useful To Me  Not Useful To Me
TraderBen Supreme	08-May-2026 09:09        TraderBen About Contact  Quote this Post!
x 0   x 0  Alert Admin	u que since last night ah? piscesmonkey      ( Date: 08-May-2026 09:05) Posted: Sold off 100lots at 265 piscesmonkey      ( Date: 07-May-2026 17:09) Posted: I bought back at 240 see tmr can sell at 26
Useful To Me  Not Useful To Me
piscesmonkey Supreme	08-May-2026 09:05        piscesmonkey About Contact  Quote this Post!
x 0   x 0  Alert Admin	Sold off 100lots at 265 piscesmonkey      ( Date: 07-May-2026 17:09) Posted: I bought back at 240 see tmr can sell at 265 Barcalo      ( Date: 07-May-2026 16:51) Posted: Now massive road block at 260.....
Useful To Me  Not Useful To Me
TraderBen Supreme	07-May-2026 20:58        TraderBen About Contact  Quote this Post!
x 0   x 0  Alert Admin	Huat Liao. 2days bought more than 6m shares
Useful To Me  Not Useful To Me
SmallSmall Supreme	07-May-2026 20:17        SmallSmall About Contact  Quote this Post!
x 0   x 0  Alert Admin	Substantial shareholder Q& M bought 4,280,800 @ avg $0.2438 from open market today. 4.2 mil shares removed from market. Likely to trend higher.
Useful To Me  Not Useful To Me

                                                         First   < Newer   81-100 of 757   Older>   Last